Early-stage
Investor-readiness consulting
Valuation
Licensing (incl. valuation & structuring)
MBO
Clinical stage
R&D tax incentive
VC funding
Valuation
Licensing (incl. valuation & structuring)
MBO
Medium/Later
IPO
Sell-side M&A
Our mission is to ensure that potentially game-changing research reaches its full potential in the market. That’s why we are on a crusade to provide early- and clinical-stage life science companies access to the same strategic financial advice - including valuation and licensing capability - that is available for the big pharma.
Why do you need Sherwood as your advisor?
Preparation
You have one shot with VCs and investors, so we ensure you're fully prepared to make it count.
Experience
With experience working with hundreds of companies, we help you avoid mistakes and ensure you don't have to go it alone.
Expertise
Outsource your deal team for expertise in competitive negotiations, valuations, and financing. Level the playing field with big pharma by having Sherwood by your side.
Network
Access our close personal network of 100+ leading VCs and investors who prioritise meeting investee companies introduced by us.
Companies using corporate finance advisors achieved 12% higher revenue multiples (2.54x) compared to companies without advisor help (2.26x) in the last 5 years in Australia.
Our references
15+
companies advised
$120M+
transaction value
100+
investor partners
in 12
countries on 4 continents
Let’s talk!
Let's start the conversation and explore how we can catalyse your success in the competitive biotech landscape.
Sherwood Global Partners | North America | Europe | Asia | Australia
© 2025 Sherwood Global Partners | Privacy Policy | Disclaimer | Terms and Conditions